Relationship between the rewarding and aversive effects of morphine and amphetamine in individual subjects

被引:0
作者
Andrey Verendeev
Anthony L. Riley
机构
[1] American University,Psychopharmacology Laboratory, Department of Psychology
来源
Learning & Behavior | 2011年 / 39卷
关键词
Morphine; Amphetamine; Conditioned taste aversion; Conditioned place preference; Concurrent assessment; Individual differences;
D O I
暂无
中图分类号
学科分类号
摘要
Drugs of abuse have been reported to produce both rewarding and aversive effects, as evidenced by their ability to induce both conditioned place preferences (CPPs) and conditioned taste aversions (CTAs), respectively. Although several attempts have been made to assess the relationship between the rewarding and aversive effects of drugs in independent groups, it is unknown to what extent (if any) preferences and aversions are related in individual animals. The present study assessed this relationship by examining the ability of morphine (5 and 10 mg/kg) and amphetamine (3 and 5 mg/kg) to induce both place preferences and taste aversions in the same animal, using a concurrent CTA/CPP design. There was no consistent relationship between the ability of morphine or amphetamine at either dose to increase time spent on the drug-paired side and the ability to suppress consumption of the drug-paired taste. These results support the position that drugs of abuse have multiple stimulus effects, both rewarding and aversive, that condition place preferences and taste aversions independently.
引用
收藏
页码:399 / 408
页数:9
相关论文
共 50 条
  • [21] Sensitivity to rewarding or aversive effects of methamphetamine determines methamphetamine intake
    Shabani, S.
    McKinnon, C. S.
    Reed, C.
    Cunningham, C. L.
    Phillips, T. J.
    GENES BRAIN AND BEHAVIOR, 2011, 10 (06) : 625 - 636
  • [22] Long-lasting rewarding effects of morphine induced by drug primings
    Do Couto, BR
    Aguilar, MA
    Rodríguez-Arias, M
    Miñarro, J
    BRAIN RESEARCH, 2005, 1050 (1-2) : 53 - 63
  • [23] STRAIN DIFFERENCES IN THE REWARDING AND DOPAMINE-RELEASING EFFECTS OF MORPHINE IN RATS
    SHOAIB, M
    SPANAGEL, R
    STOHR, T
    SHIPPENBERG, TS
    PSYCHOPHARMACOLOGY, 1995, 117 (02) : 240 - 247
  • [24] Rewarding or aversive effects of buprenorphine/naloxone combination (Suboxone) depend on conditioning trial duration
    Canestrelli, Corinne
    Marie, Nicolas
    Noble, Florence
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2014, 17 (09) : 1367 - 1373
  • [25] The antipsychotic aripiprazole selectively prevents the stimulant and rewarding effects of morphine in mice
    Almeida-Santos, Ana F.
    Gobira, Pedro H.
    Souza, Diego P.
    Ferreira, Renata C. M.
    Romero, Thiago R.
    Duarte, Igor D.
    Aguiar, Daniele C.
    Moreira, Fabricio A.
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2014, 742 : 139 - 144
  • [26] Early maternal separation and sex differences in the aversive effects of amphetamine in adult rats
    Roma, Peter G.
    Davis, Catherine M.
    Kohut, Stephen J.
    Huntsberry, Mary E.
    Riley, Anthony L.
    PHYSIOLOGY & BEHAVIOR, 2008, 93 (4-5) : 897 - 904
  • [27] Effects of angiotensin II and captopril on rewarding propreties of morphine
    Hosseini, Mahmoud
    Sharifi, Mohammad Reza
    Alaei, Hojatallah
    Shafei, Mohammad Naser
    Karimooy, Habib Allah Nemati
    INDIAN JOURNAL OF EXPERIMENTAL BIOLOGY, 2007, 45 (09) : 770 - 777
  • [28] Effects of Serial Polydrug Use on the Rewarding and Aversive Effects of the Novel Synthetic Cathinone Eutylone
    Manke, Hayley N.
    Nunn, Samuel S.
    Sulima, Agnieszka
    Rice, Kenner C.
    Riley, Anthony L.
    BRAIN SCIENCES, 2023, 13 (09)
  • [29] Separation stress, litter size, and the rewarding effects of low-dose morphine in the dams of maternally separated rats
    Roma, Peter G.
    Huntsberry, Mary E.
    Riley, Anthony L.
    PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2007, 31 (02) : 429 - 433
  • [30] Differences in locomotor response to an inescapable novel environment predict sensitivity to aversive effects of amphetamine
    Kunin, D
    Gaskin, S
    Borjas, MB
    Smith, BR
    Amit, Z
    BEHAVIOURAL PHARMACOLOGY, 2001, 12 (01): : 61 - 67